Patent · US Active

Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

US8349353B2 · kind B2 · utility

17Cited by
9References
5Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 29, 2009
Grant dateJan 8, 2013
Priority date
Expiry dateFeb 16, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0046
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with cytotoxic agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.